Small human hepatocytes in rotary culture for treatment of alcohol addicts? A pilot study

Alcoholism: Clinical and Experimental Research

Volumn 31, Issue 5, 2007, Pages 729-736

  Pavlic, Marion ^a   Libiseller, Kathrin ^a   Hermann, Martin ^a   Hengster, Paul ^a   Margreiter, Raimund ^a   Wurm, Martin ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Alcohol; Benzodiazepines; Bioartificial Liver; Rotary Cell Culture; Small Human Hepatocytes

Indexed keywords

ALBUMIN; BENZODIAZEPINE; CYTOCHROME P450; DIAZEPAM; GLUCOSE; LACTATE DEHYDROGENASE; OXAZEPAM; UREA;

ALCOHOL METABOLISM; ALCOHOLISM; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SIZE; CELL VIABILITY; CONJUGATION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG METABOLISM; ENZYME RELEASE; EVAPORATION; GLUCOSE INTAKE; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER FAILURE; PILOT STUDY; PRIORITY JOURNAL; SIMIAN VIRUS 40; STATISTICAL SIGNIFICANCE; UREA CYCLE;

ALCOHOLISM; CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE; CULTURE MEDIA; CYTOCHROME P-450 ENZYME SYSTEM; DIAZEPAM; HEPATOCYTES; HUMANS; HYPNOTICS AND SEDATIVES; L-LACTATE DEHYDROGENASE; LACTIC ACID; LIVER DISEASES, ALCOHOLIC; LIVER, ARTIFICIAL; MICROSCOPY, CONFOCAL; OXAZEPAM; PILOT PROJECTS; UREA; XENOBIOTICS;

EID: 34247150653     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2007.00357.x     Document Type: Article

References (33)

1. Castaneda R, Cushman P (1989) Alcohol withdrawal: a review of clinical management. J Clin Psychiatry 50:278-284.
2. Daeppen JB, Gache P, Landry U, Sekera E, Schweizer V, Gloor S, Yersin B (2002) Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 162:1117-1121.
3. Dawe S, Richmond R (1997) Controlled drinking as a treatment goal in Australian alcohol treatment agencies. J Subst Abuse Treat 14:81-86.
4. Everhart JE, Beresford TP (1997) Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg 3:220-226.
5. Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, Schoenhofen M (1999) Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. Artif Organs 23:81-86.
6. Guengerich FP (1991) Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 266:10019-10022.
7. He YA, Roussel F, Halpert JR (2003) Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling. Arch Biochem Biophys 409:92-101.
8. Hochleitner B, Hengster P, Duo L, Bucher H, Klima G, Margreiter R (2005) A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity. Artif Organs 29:58-66.
9. Iwata H, Sajiki T, Maeda H, Park YG, Zhu B, Satoh S, Uesugi T, Ikai I, Yamaoka Y, Ikada Y (1999) In vitro evaluation of metabolic functions of a bioartificial liver. ASAIO J 45:299-306.
10. Knowles JA, Ruelius HW (1972) Absorption and excretion of 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one (oxazepam) in humans. Determination of the drug by gas-liquid chromatography with electron capture detection. Arzneimittelforschung 22:687-692.
11. Kobayashi N, Okitsu T, Tanaka N (2003) Cell choice for bioartificial livers. Keio J Med 52:151-157.
12. Lucey MR, Carr K, Beresford TP, Fisher LR, Shieck V, Brown KA, Campbell DA, Appelman HD (1997) Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology 25:1223-1227.
13. Martina Y, Marcucci KT, Cherqui S, Szabo A, Drysdale T, Srinivisan U, Wilson CA, Patience C, Salomon DR (2006) Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection. J Virol 80:3135-3146.
14. Matthews VB, Yeoh GC (2005) Liver stem cells. IUBMB Life 57:549-553.
15. McCullough AJ (1999) in Schiff's Diseases of the Liver, 8th ed, (Schiff ER, Sorrell MF, Maddrey WC eds), pp 941-971. Lippincott Williams & Wilkins, Philadelphia.
16. Miller WR, Meyers RJ, Hiller-Sturmhofel S (1999) The community- reinforcement approach. Alcohol Res Health 23:116-121.
17. Millis JM, Losanoff JE (2005) Technology insight: liver support systems. Nat Clin Pract Gastroenterol Hepatol 2:398-405.
18. Mitaka T, Kojima T, Mizuguchi T, Mochizuki Y (1995) Growth and maturation of small hepatocytes isolated from adult rat liver. Biochem Biophys Res Commun 214:310-317.
19. National Institutes of Health Consensus Development Conference Statement (1984) Liver transplantation. Hepatology 4 (suppl): 107S.
20. Porter TD, Coon MJ (1991) Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms. J Biol Chem 266:13469-13472.
21. Puz CA, Stokes SJ (2005) Alcohol withdrawal syndrome: assessment and treatment with the use of the Clinical Institute Withdrawal Assessment for Alcohol-revised. Crit Care Nurs Clin North Am 17:297-304.
22. Reuben A (2006) Alcohol and the liver. Curr Opin Gastroenterol 22:263-271.
23. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D (2003) Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 39:984-990.
24. Scharschmidt BF (1984) Human liver transplantation: analysis of data on 540 patients from four centers. Hepatology 4:95S-101S.
25. Shibata C, Mizuguchi T, Kikkawa Y, Nobuoka T, Oshima H, Kawasaki H, Kawamoto M, Katsuramaki T, Mitaka T, Hirata K (2006) Liver repopulation and long-term function of rat small hepatocyte transplantation as an alternative cell source for hepatocyte transplantation. Liver Transpl 12:78-87.
26. Sobell MB, Sobell LC (1973) Alcoholics treated by individualized behavior therapy: one year treatment outcome. Behav Res Ther 11:599-618.
27. Sobell MB, Sobell LC (1995) Controlled drinking after 25 years: how important was the great debate? Addiction 90:1149-1153.
28. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Lohr M, Liebe S, Schareck W, Hopt UT, Schmidt R (1999) Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319-330.
29. Starzl TE, Van Thiel D, Tzakis AG, Iwatsuki S, Todo S, Marsh JW, Koneru B, Staschak S, Stieber A, Gordon RD (1988) Orthotopic liver transplantation for alcoholic cirrhosis. JAMA 260:2542-2544.
30. Webb K, Shepherd L, Day E, Masterton G, Neuberger J (2006) Transplantation for alcoholic liver disease: report of a consensus meeting. Liver Transpl 12:301-305.
31. Wolf CF, Munkelt BE (1975) Bilirubin conjugation by an artificial liver composed of cultured cells and synthetic capillaries. Trans Am Soc Artif Intern Organs 21:16-27.
32. World Health Organization (2002) The world health report 2002. Reducing risks, promoting healthy life.
33. Yates WR, Martin M, LaBrecque D, Hillebrand D, Voigt M, Pfab D (1998) A model to examine the validity of the 6-month abstinence criterion for liver transplantation. Alcohol Clin Exp Res 22:513-517.